Reliability of implantable central venous access devices in patients with cancer

G. V. Stanislav, R. J. Fitzgibbons Jr, R. T. Bailey Jr, J. A. Mailliard, P. S. Johnson and J. B. Feole
Department of Surgery, Creighton University School of Medicine, Omaha, NE 68131.

We reviewed complications requiring removal of Hickman catheters (HCs) and implantable central venous access devices (ICVADs) in patients with cancer over a 30-month period. The study was unique in the sense that patients chose which system would be inserted, unless continuous infusion was anticipated. A total of 115 systems were inserted in 102 patients. Forty-four HCs were inserted in 34 patients (total system days, 8533 [mean, 194 days]); 71 ICVADs were inserted in 68 patients (total system days, 18,681 [mean, 263 days]). Complications required removal in 38.6% of HCs and 18.3% of ICVADs. Complication rates were one in 501 days in the HC group and one in 1450 days in the ICVAD group. Although 15 systems were removed for suspected infection, closer analysis revealed that bacteremia ultimately found to be unrelated to the catheter resulted in premature removal in many cases. The catheter tip was located high in the superior vena cava or in the subclavian vein in all systems removed due to thrombosis. Miscellaneous complications in HCs included dislodgment and catheter embolism. The increased longevity, lower complication rate, and decreased maintenance requirements in the use of ICVADs support their superiority over HCs in the treatment of patients with cancer.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Thrombotic Complications of Central Venous Catheters in Cancer Patients
Kuter
The Oncologist 2004;9:207-216.
ABSTRACT | FULL TEXT  

Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients
Biffi et al.
Ann Oncol 2004;15:296-300.
ABSTRACT | FULL TEXT  

Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients
Verso and Agnelli
JCO 2003;21:3665-3675.
ABSTRACT | FULL TEXT  

Catheter-related Upper Extremity Deep Venous Thrombosis in Cancer Patients: A Prospective Study Based on Doppler US
Luciani et al.
Radiology 2001;220:655-660.
ABSTRACT | FULL TEXT  

Editorial II: Safe placement of central venous catheters: where should the tip of the catheter lie?
Br J Anaesth 2000;85:188-191.
FULL TEXT  

Totally Implantable Venous Access Ports Systems for Patients Receiving Chemotherapy for Solid Tissue Malignancies: A Randomized Controlled Clinical Trial Examining the Safety, Efficacy, Costs, and Impact on Quality of Life
Bow et al.
JCO 1999;17:1267-1267.
ABSTRACT | FULL TEXT  

Ten-Year Survival of a Broviac Catheter
Heimburger
Nutr Clin Pract 1992;7:74-76.
ABSTRACT